Day: June 17, 2020

TULSA, Okla., June 17, 2020 (GLOBE NEWSWIRE) — Laredo Petroleum, Inc. (NYSE: LPI) (“Laredo” or the “Company”), today named Bryan Lemmerman as Senior Vice President and Chief Financial Officer, effective June 30, 2020. Michael Beyer will be leaving the Company effective June 17, 2020.Mr. Lemmerman has more than 15 years of experience in the energy exploration and production industry, including an extensive background in strategic planning and business development. He previously spent 10 years with Chesapeake Energy Corporation (“Chesapeake”), serving in financial roles with increasing responsibility, most recently as Vice President – Business Development and Treasurer. Prior to joining Chesapeake, Mr. Lemmerman was a portfolio manager at Highview Capital Management and Ritchie Capital Management,...

FREEHOLD, NJ, June 17, 2020 (GLOBE NEWSWIRE) — UMH Properties, Inc. (NYSE:UMH) announced today that Samuel A. Landy, President and Chief Executive Officer, has been invited to present at The Impact of the COVID-19 Pandemic on Real Estate webinar, presented by Maxim Group and M-Vest on Tuesday, June 23, 2020.UMH Properties, Inc. will participate in a panel discussion on the impact of the COVID-19 pandemic and the pre-pandemic, pandemic and post-pandemic strategy and operations of the company.To access the panel discussion, please RSVP at https://m-vest.com/insights/blog/covid-19-series-the-impact-on-real-estate?utm_source=Conference&utm_medium=press_release&utm_campaign=COVID19_REIT&utm_term=UMH&utm_content=GeneralWebinar Details:Panel Session Title: The Impact of the COVID-19 Pandemic on Real EstateDate and Time:...

LONG BEACH, N.Y., June 17, 2020 (GLOBE NEWSWIRE) — Ipsidy Inc. (www.ipsidy.com) [OTCQB:IDTY], a leading provider of secure, mobile biometric identity solutions, including Identity as a Service (IDaaS), is pleased to announce it has joined the Temenos MarketPlace. This is the first in a series of anticipated announcements centered around our new go-to-market strategy, primarily partnering with companies serving or supporting key technology initiatives for the world’s largest enterprises.Temenos (SIX: TEMN) is a global banking software provider to over 3,000 financial institutions, including 41 of the world’s top 50 banks. The Temenos MarketPlace is a platform that easily and quickly connects banks to innovative technologies. With the addition of Ipsidy’s IDaaS platform, Temenos clients now will have access to the Ipsidy suite of...

~ Biopharma Executive Brings 35 Years of Research and Development Leadership ~LEXINGTON, Mass. and AMSTERDAM, June 17, 2020 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the appointment of Leonard E. Post, Ph.D. to its Board of Directors. Dr. Post, who will also chair the Company’s Research & Development Committee, has extensive biotechnology industry experience including previous global R&D leadership roles at BioMarin and Onyx Pharmaceuticals.“It is with great pleasure that we nominate Len to the uniQure board,” stated Matthew Kapusta, chief executive officer of uniQure.  “His considerable biotechnology experience, including his important work in gene therapy, are valuable assets for uniQure...

NEW HAVEN, Conn., June 17, 2020 (GLOBE NEWSWIRE) — Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions, today announced that management will present via a virtual fireside chat, as well as host virtual investor meetings, at the 2020 BMO Capital Markets Prescriptions for Success Healthcare Conference on June 23, 2020:Presentation Time: 11:30 a.m. ETA live webcast of the virtual fireside chat can be accessed by visiting ‘News & Events’ in the ‘Investors & News’ section on the Company’s website at www.trevitherapeutics.com. An archived replay of the webcast will also be available for 30 days on the Company’s website following the conference.The Company’s corporate presentation...

BEIJING, June 17, 2020 (GLOBE NEWSWIRE) — Secoo Holding Limited (“Secoo” or the “Company”) (NASDAQ: SECO), ‎Asia’s largest online integrated upscale products and services platform, today announced that its Board of Directors (the “Board”) has approved the appointment of Ms. Qi Zhu as a member of the Board, effective immediately. At the same time, Ms. Jeacy Jisheng Yan will step down from the Board with immediate effect after nine years of dedicated service.Ms. Zhu currently serves as Vice President of Qudian Inc. (“Qudian”, NYSE:QD) and is responsible for Qudian’s financial analysis and capital markets activities. Prior to joining Qudian, Ms. Zhu worked at the investment banking department of Credit Suisse in Hong Kong, where she worked on various capital markets transactions. Ms. Zhu holds a BBA degree from the University of Hong...

WALTHAM, Mass., June 17, 2020 (GLOBE NEWSWIRE) — Eloxx Pharmaceuticals, Inc., (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis and other diseases caused by nonsense mutations limiting production of functional proteins, today announced that enrollment in its Phase 2 clinical trial for ELX-02 in cystic fibrosis has been resumed in Israel and Europe after being temporarily paused in response to the COVID-19 pandemic.“We are pleased that enrollment in our Phase 2 clinical trial in cystic fibrosis has been resumed in Israel and Europe, however, our U.S. trial remains temporarily paused due to the COVID-19 pandemic as  the health and safety of our employees, healthcare workers, and patients must be our highest priority during this crisis,”...

AURORA, Ill., June 17, 2020 (GLOBE NEWSWIRE) — Westell Technologies, Inc. (NASDAQ: WSTL), a leading provider of high-performance network infrastructure solutions, today announced results for its fiscal 2020 fourth quarter ended March 31, 2020 (4Q20) and its fiscal year ended March 31, 2020 (FY20).  Management will host a conference call to discuss financial and business results tomorrow, Thursday, June 18, 2020 at 9:30 AM Eastern Time (details below).“The fourth quarter was difficult, and our results were affected by the COVID-19 pandemic.  We saw a drop in our average daily orders during the quarter, likely due to customers affected by the stay-at-home orders and economic uncertainty.  We also experienced supply chain delays that pushed shipments into the following quarter,” said Westell’s President and CEO Tim Duitsman.“Since...

EMERYVILLE, Calif., June 17, 2020 (GLOBE NEWSWIRE) — Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced the completion of its evaluation of ADS-5102 in multiple sclerosis patients with walking impairment (MSW).A comprehensive analysis of the INROADS Phase 3 data validated the top line results announced in December 2019 and informed a revised target product profile reflecting the scale of clinical benefit observed in the study. Additional patient, physician, and payer research based on the revised profile projected a limited commercial opportunity. Further engagement with the U.S. Food and Drug Administration (FDA) to fully understand a potential path to submission confirmed the need...

SOUTH SAN FRANCISCO, Calif., June 17, 2020 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ:CBIO) today announced that it is offering shares of its common stock in an underwritten public offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. In addition, Catalyst expects to grant the underwriters of the offering a 30-day option to purchase up to an additional 15% of the number of shares of common stock offered in the public offering. All of the shares in the offering are being offered by Catalyst.Catalyst anticipates using the net proceeds from this offering for general corporate purposes, which may include research and development activities in its complement program, clinical and...